India can easily do synthesis of antiviral drug - Remdesivir: Former ICMR Director

May 02, 2020

New Delhi [India], May 3 : India can easily do the synthesis of antiviral drug - Remdesivir - if allowed by the US-based pharma...

Monoclonal antibodies to treat COVID patients should always be used in pairs to minimise mutation formation: former ICMR DG

May 31, 2021

New Delhi [India], May 31 : Monoclonal antibodies, recently introduced in India as an antibody therapy to treat COVID-positive patients, are being used to...

Efficient manufacturing system needed to lower cost of Monoclonal antibody therapy, says former ICMR DG Nirmal Ganguly

May 30, 2021

New Delhi [India], May 30 : The cost of Monoclonal antibody therapy, which was recently approved by India's top drug regulatory body for treatment...

Jodhpur Philanthropist builds a dedicated center to encourage Blood Donations

Dec 30, 2023

Jodhpur (Rajasthan) [India], December 30: A philanthropist from Jodhpur, and the Founder of one of the leading education companies - Utkarsh Classes, Dr Nirmal...

"Two-thirds of total patients of NTDs are in India": Former DG of ICMR

Feb 09, 2024

In view of the increased number of NTDs in India, Nirmal Kumar Ganguly, former director general of the ICMR, said that there are 172...

NC losing support base in J-K: BJP leader Nirmal Singh

Oct 22, 2021

New Delhi [India], October 22 : Attacking National Conference (NC) chief Farooq Abdullah's statement that the BJP is using Balakot airstrike to derive political...